Due to a system-wide technology update, we are experiencing extremely high call volume. We appreciate your patience with our operators during this time. Thank you for choosing Fox Chase Cancer Center.
Division of General Surgery
Fox Chase Cancer Center’s board-certified general surgeons all received advanced fellowship trained in surgical oncology and perform a wide variety of procedures, including those involving the breast, abdomen, skin and gastrointestinal tract. Many procedures can be performed using minimally-invasive techniques that can shorten recovery time and reduce pain and scarring. Our general surgeons work hand-in-hand with our medical oncologists, radiation oncologists and other specialists to provide a focused treatment plan that best fits your particular needs.
-
Chief, Division of General Surgery
-
-
Allison A. Aggon, DO, FACOS
-
Richard J. Bleicher, MD, FACS
-
Jason A. Castellanos, MD, MS
-
Stephanie H. Greco, MD, FACS
-
Kelvin Kwan N. Lau, MD
-
Juan Lucas Poggio, MD
-
Andrea S. Porpiglia, MD, MSc, FACS
-
Sanjay S. Reddy, MD, FACS
-
Elin R. Sigurdson, MD, PhD, FACS, FRCS (C)
-
Anthony M. Villano, MD
-
Austin D. Williams, MD, MSEd
-
-
Advanced Practice Clinicians
-
Fox Chase Cancer Center is one of only a handful of hospitals in the Philadelphia region offering hyperthermic intraperitoneal chemotherapy (HIPEC) – a novel way of delivering chemotherapy directly to the lining of the abdominal cavity during surgery. HIPEC involves the rinsing of the abdominal cavity with a heated chemotherapy solution for up to two hours after the removal of visible tumors. The goal of this approach is to destroy any remaining microscopic cancer cells and prevent recurrence. HIPEC may be appropriate for patients with advanced cancers that have spread to the peritoneum (lining of the abdominal cavity) and those who have been told they no longer have effective treatment options.
